CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="120"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "publications.waset.org",cType: 'non-interactive',cRay: '9135e04ae9238235',cH: '0Gwii0owZkmnoM9lXwmskDkhigzj_TBP3K1_lS0VPS0-1739796343-1.2.1.1-xIAdvq_wtfn2HrXnSFxOJcO89EN.i2JZTo0PGyXkzXOCG2unmMVwBLoHNgmYw7lh',cUPMDTk: "\/abstracts\/162443\/prevalence-of-rituximab-efficacy-over-immunosuppressants-in-therapy-of-systemic-sclerosis?__cf_chl_tk=Wmafn5e_GyoRvSRCUd0r_6fwAvJCzcTAm3z0TGhj_BI-1739796343-1.0.1.1-Bux63TmjJ_JfKe44GjmK6zYXGy9OHC_cSJpPEMQmTdw",cFPWv: 'b',cITimeS: '1739796343',cTTimeMs: '1000',cMTimeMs: '120000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/abstracts\/162443\/prevalence-of-rituximab-efficacy-over-immunosuppressants-in-therapy-of-systemic-sclerosis?__cf_chl_f_tk=Wmafn5e_GyoRvSRCUd0r_6fwAvJCzcTAm3z0TGhj_BI-1739796343-1.0.1.1-Bux63TmjJ_JfKe44GjmK6zYXGy9OHC_cSJpPEMQmTdw",md: "MvSddtKw5NMkanFDSG8oCq5HLPXIBCzSTHjmuuflGbY-1739796343-1.2.1.1-OZLE19HnPv2f9BYFIGn5lWjcsEEa7hMfE7DEkC0yxJtVrEj_tTeb3yfSEWQXse0egBiUcHP7KUbgT8fOW8c3l5SmFNPQpt9K8uOpMWVFTdfdsT_IqUg8_zTHN8MtN0qD.uQk3neeY8_2nIiVYRRdETuShS_aC292KdYnMqAQEqrCeCdT6YYLmrx0D4tOsiJB3qYwWajk3NussURaTYbbr6cMDwwkTdCNjYx6C.ti3RU40j.Mmv6vVqlGnQCOXvdb792MrT2cs8uvvaJF0vBXzTGLnSrXpqQGnIIb704TcOXMiATZyDoAF9UX6QUjwJBnrDGRltrBv_PBUvGEKbMDMsqqHv1cIs92vVtUwUFeon3M6u3CKVG8xgR4Qv13hKWxyj2Ba83b8Od1Hyk65kmDtPear4XQQeBNUK0hcyZciP2RIJ9oXIxWwNE4JkPEtPvlGKwK10n1lq8wpTDk77KqJJG6VId.Glgn0moyJNixEo6T55Y_mAgRkI35rhfNIWNc5nBsi5WQTp1vzn8rd6DYMQ8DiKpEyB4Yq8o8HYbn_JNeFL8tVKNSrigoawe6PWnes2cKHEV1KGUe19RV19IIanfg.ycZDJF8iJTgsiSjgCvOvXj3f_m.XZNuCJhLtd.3bc_cylLukx5iMjTectqxgm6oYcEkIqRL1ep11Omg.AmtlPlM8XhLVGk67Bxif0LDAxvo9TJp_StqgL5zY_gsCuvWsEGpz1Wv_aDYRfOwLxKzoOirK8q7B92LLjL_4UhRAFdSJNzR79Q.LSQ1qRF0vCShXlER4iB.EGkNZAZu9Rn95zuF9timTLMUYeU2Hc6P3p.pHusM31dG8E1h8dfdXJHvYWT88yYucp1DRp832n9TVAkosGmRKxUeQZmuKJAZruRPDUucmTZzaqVq17sbQUDbiSS29EdwPc8fBzRXFQhBpIjvAoEZRfF0vwEDsgsq8oA_zp3vANyuk4Q68ffDkBvpCoSvs1imTWsJSmR0yw60dNpJnPwIn5.deT_Og3poq_3ODI7i1_AVo01CIU4Y0NP2m.9BM0PK6kwFk1mTMrr1UOYyootkabXWc7D6ZXQOMJdKIDLbhG_bxj8MKExHkA0lxnY2Loa9b0x2Pqd7Qjp8AdHw9tLz2bo0g57RycJ6YN86UKo_gFYFtN0SKCZHC6W_XBsdW0etcqf55D1MqTsLUx8URrzj_Bw0y6zkG1F6r5VoZYJeZbDHWsMy3rn_mCia4j2sa2I3qQdQ5CdhU5kWGkhZDVBTMc1dn7uEKy1DAoyFhaaoGbVbOxiUajR0.RkzPd4DAKDxFNhcx1uczcsQkEB9MQQgxIsKHsTZ1K1351xCLFimu5Ydc8cUyPOU5ntTQE4kuxf29Fc4T3IJkQgkzF7NWfxwRbmQzXY9qAaNljeCQbqt.RYr1kRgNrYqxXrxXP5nsx.D8uDejlGbb2psfiGAsJ7h.4oooBIlBxfU61_hUa_u2YuFvqadbCMR.bO4FO0u4s62ZoGagNbaxMWr_RUpC4YX.N31_YeximVWeCG392VSG4JFt_clZGo_bp2tvWhTP2aWr0Du34tldA5C1OKPDQER7UvAKLyHrg6mk58u2SAexBU1kTT2pDOBu_HYVKYYMFKijx2n4wq9wK0Z.jbxTaQhqsrM_YWW7CTOa3SAt.ark218eGj.eTY.DikiDcYHeWowApav2_QhU0aRK07vUZ3seac2EVRl_dpY5u.bVKWf30DJG0JoeY0iH.oGg5M1eK4hr_8Ivt_bqg4ckUGPVgXhN2IqmgCxX6cxiAolW13DyMaC67sdsKVfX1awlDYaXU.xbdSEKEYSMimayDg.3FipPNTUCe6zJjekKzwZ4AAfB9wAXu.ZmdqL7AiDt9SWtENM3NDsO4J02BbYb0.YUWjvPtf732ArVlWNi_aeP6uQ134HnnAKg7HNqtX1yvNsVFz5za.PZj1tJJr9sTTYxe5omfUQaMPri.ei20wA_aAtBzzyj7HpsAlU0bdVJKYEosR3bJ.jsEDMcQrvy4f6IaWI0P7e6lEg3kqbTi7iO2BktYA292CZT__aLqeQs90APCpAtUL3VtabdV.9SaHeIr7wuyltLxKlj_FEmO92.4mxa3v.TC.maZM5ipgt554eG.tt3ZYPecbZFIE",mdrd: "nqEscXQzAxvkzvDDmj3U8UWAZvmnxoGtfuF1U.I3RBQ-1739796343-1.2.1.1-dY83pFy9IQvfYShZn27G_SGOeIGjvSlvCR_d.m6753am7MomrS5cqH4fFSKVaMTwzb0RYxztjQO0WW2RQU4iUXTxHZrZDNii1.sO9BdUHUBBmMwXy_EjB_LC7iciFHgynDSwOWFz7mzsXe3XXrz2WAmazm55mFwk7uXEOGSMx_AwIrJWMXNNDN4qXerMLIjP_44P0ZfvUmdO1nGnnZRXzXmuNiGrQEWuIhfIUXbUgPAOSaYhnLLmYMSyd.yb83bYGSnlbPqEY9oRveh.9o2OhLBXzUdcF78kACUFaBigO_cfVEqMC5xJX4Vj.nhmuWaPJHL04TBmQOkb2yqORMbxlwLseZjJRdxbObqw2J64CWAANluKEflpXqCVVvqhxoGeFBvUf88axjpnjRtaA8TkWpaImKpB4sYzxOa1L.titgnJgfUS58kq0arctQ3IvBAVBEWCAQlbWFMXc32qBKsdxhNEXLBRysGsCKLkSxPDCQ0wPAfKnAubGH7ojkMQsJx0QVtx_L4ZSFBnrIBfYvGDzaewYL4Ay3Tj8UfJHnjwLkXm1YLLiETXFFco9lbHygjMnefMM202Seed1MDpP.i9Xgs6que8Q9qJNUzbhVM6Xu24NmMHph4GE8ogJ2wTBBE.O232Bi_JLwkuRMV3oH5xF4YzpQ5ZnRnBUvXFwC5j4vUX32glaxISLrHM9t9UPtov1UqCnltIO4cg8Zrc6sZYE5.lCapfVcF2.VrAM4xHLcZSB.S9_f3rMJH3PByFrZK2k0xJKcLzZ88CmMX7LbSLvSNnL58KDIaKZkmTZlOjC32475eS3ZUoGinhv3_LcemBNFjVBU_eJvlFKNRZiUYIAQSFzSifiRrudmZHmb_jMkpxIRSy1hljSJFuVem6hJ79vcgkxc8TthreuxLXYev_Ej_ohVcmZK5U8J7OGwonPAe1JF0w0jZij4gXQeG3Dok8yLttRQ9FEdw5CFm_qJsodTEws9T6JFj8ic7rUe9FoLQIKoNaENCpxov_5CENqzKMOV8HFh5m89IFSZeilI.mCMIgS4EAZpf87K13wZYSg0Ywuz6in749R.TrmWsDVyBThXOjMka_QrjpOJ3t2VBKpJhHv1TVxsbD4cRmmz3Fb7CgOyIXj5LgqnlOpmxcda8CAQSn6oJqYPUhnfc3YJPwJzoFGNneicg9NJbk9TldZSV8KBb8RtwF8_KPuEkD7LoPdPIu0w2ZIlE9qPdRpgO9AR0t13vAtGy7E29cfKtj1Rfq_8.I6w1xO3ZcZXFZKPH9DdsZJDoNDLoMT6tizjAgRQQqIeG7X8FIl4oO9kzcrFNVwoGtIKO3WOGrIKz9MU_PM0CvOMbc9o0c4hNq9BXxKj0omcbmiQsEtgZ3YkV.URV_zOzgJL2UaQLqmlNrurs2gCJ4gT7qzlNTc9_8OKW.cBkI0QZQLAyCVYZFqkCBF51UDaoo.SUwCydusoyRzfzWNmB8QqSu50VXeyrmOQYJbRLKbKggmWx58TvK86FbsJTd4pZTund8yPasoS5uF3bP51mQvsuTx5UaHg5fDMR.hoHOZVlhuGrHD.4XrkpjWSoCm0nT9Iyujcbdfk.tdIAFdJX_QmWKosQQ9xAkLf.XsZT5tLfEwmlwdvjtJtgEVbPOG.j367lWsCPvDh3SxZ4n3FRPmeUMLW4XmrsVgx1ajy8GaKDyLOpu22H1CYuPMDLkSc8oz3b8QzEI0lleaekQpZf7YS524B6WGDd_1RM5Ub_OuWkFGDF7jUQ5w86jPw0hMusiS5WbwiLEK74WsXOtttUTesRwr9W.uxuKHV3Ecl0T4xDUSWTSW2PcYkPD0uMuw93b4v8WkmqjlGE_ZTChHMmcmz.Vb1JWgB3nAGKjPh53BmRBP35acVwsuBkggMwD_bfZZ22yv1HVXIkCqrvlkEbCJ4iWjNkKlB_Gyx.Re_Tx6srXj4grbNMPCGsV6bN.oAaUSIJrbuaSzpD3Ez3eWDwqibUdfQvqbyZhJJLX81aKuQlzDIm45fEiWbg0LoA"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=9135e04ae9238235';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/abstracts\/162443\/prevalence-of-rituximab-efficacy-over-immunosuppressants-in-therapy-of-systemic-sclerosis?__cf_chl_rt_tk=Wmafn5e_GyoRvSRCUd0r_6fwAvJCzcTAm3z0TGhj_BI-1739796343-1.0.1.1-Bux63TmjJ_JfKe44GjmK6zYXGy9OHC_cSJpPEMQmTdw" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>